Prostate Cancer Targeting by Replication-Selective Adenoviral Mutants: Combination Treatments with Phytochemical Drugs

被引:0
|
作者
Adam, Virginie [1 ]
Oberg, Daniel [1 ]
Lemoine, Nick [1 ]
Hallden, Gunnel [1 ]
机构
[1] Barts & London Queen Marys Sch Med & Dent, CR UK Clin Ctr, Ctr Mol Oncol & Imaging, Inst Canc, London, England
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:S320 / S320
页数:1
相关论文
共 50 条
  • [21] Targeting of adenoviral vectors for gene therapy of prostate cancer
    CH Bangma
    Prostate Cancer and Prostatic Diseases, 2000, 3 : 308 - 312
  • [22] Transductional targeting of adenoviral vectors to prostate cancer in vitro
    CH Bangma
    R Kraaij
    A van Rijswijk
    HJ Haisma
    V van Beusechem
    W Gerritsen
    Prostate Cancer and Prostatic Diseases, 1999, 2 : S5 - S5
  • [23] Targeting of adenoviral vectors for gene therapy of prostate cancer
    Bangma, CH
    PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (04) : 308 - 312
  • [24] Gene therapy for pancreatic cancer targeting the genomic alterations of tumor suppressor genes using replication-selective oncolytic adenovirus
    Sunamura M.
    Oonuma M.
    Motoi F.
    Abe H.
    Saitoh Y.
    Hoshida T.
    Ottomo S.
    Horii A.
    Matsuno S.
    Human Cell, 2002, 15 (3) : 138 - 150
  • [25] A Cox-2 promoter-based replication-selective adenoviral vector to target the Cox-2-expressing human bladder cancer cells
    Shirakawa, T
    Hamada, K
    Zhang, ZJ
    Okada, H
    Tagawa, M
    Kamidono, S
    Kawabata, M
    Gotoh, A
    CLINICAL CANCER RESEARCH, 2004, 10 (13) : 4342 - 4348
  • [26] Replication-selective virotherapy for cancer: Biological principles, risk management and future directions
    Kirn, D
    Martuza, RL
    Zwiebel, J
    NATURE MEDICINE, 2001, 7 (07) : 781 - 787
  • [27] Replication-selective virotherapy for cancer: Biological principles, risk management and future directions
    David Kirn
    Robert L. Martuza
    James Zwiebel
    Nature Medicine, 2001, 7 : 781 - 787
  • [28] A novel assay to assess primary human cancer infectibility by replication-selective oncolytic adenoviruses
    Wang, YH
    Thorne, S
    Hanock, J
    Francis, J
    An, T
    Reid, T
    Lemoine, N
    Kirn, D
    Halldén, G
    CLINICAL CANCER RESEARCH, 2005, 11 (01) : 351 - 360
  • [29] Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer
    Hermiston, T
    JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (09): : 1169 - 1172
  • [30] Replication-selective oncolytic viruses in the treatment of cancer (vol 12, pg 141, 2005)
    Everts, B
    van der Poel, HG
    CANCER GENE THERAPY, 2005, 12 (04) : 438 - 438